1. Home
  2. GPRO vs MXCT Comparison

GPRO vs MXCT Comparison

Compare GPRO & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

N/A

Current Price

$1.19

Market Cap

119.4M

ML Signal

N/A

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

N/A

Current Price

$1.01

Market Cap

136.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GPRO
MXCT
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.4M
136.2M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
GPRO
MXCT
Price
$1.19
$1.01
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $4.11
AVG Volume (30 Days)
★ 15.3M
331.9K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.08
N/A
EPS
N/A
★ N/A
Revenue
★ $651,542,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$35.48
$18.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.57
$0.64
52 Week High
$2.73
$1.86

Technical Indicators

Market Signals
Indicator
GPRO
MXCT
Relative Strength Index (RSI) 47.07 29.53
Support Level $0.68 $0.98
Resistance Level $1.32 $1.27
Average True Range (ATR) 0.07 0.05
MACD -0.03 -0.01
Stochastic Oscillator 4.76 16.20

Price Performance

Historical Comparison
GPRO
MXCT

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: